Skip to content
OpenCapital
Get started

VolitionRX Limited VNRX Q4 2024 Annual earnings

Reported March 31, 2025 · After market close

Revenue$191.7KMiss by $353.7K
EPS-$0.06In line
Revenue estimate$545.3K
EPS estimate-$0.06

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$442.0K
EPS estimate-$0.70

Versus estimates

Revenue

Q1 2026$985.1KMiss by $534.2KQ4 2025$420.0KMiss by $333.6KQ3 2025$627.3KMiss by $86.8KQ2 2025$406.7KMiss by $474.3KQ1 2025$246.4KMiss by $837.6K
Q4 2024$191.7KMiss by $353.7K

Diluted EPS

Q1 2026-$0.97Miss by $0.27Q4 2025-$0.05Miss by $0.01Q3 2025-$0.04In lineQ2 2025-$0.06Miss by $0.01Q1 2025-$0.06In line
Q4 2024-$0.06In line

Ask the moment VolitionRX Limited reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did VolitionRX Limited report Q4 2024 earnings?
VolitionRX Limited (VNRX) reported Q4 2024 earnings on March 31, 2025 after market close.
What were VolitionRX Limited's Q4 2024 revenue and EPS?
VolitionRX Limited reported revenue of $191.7K and eps of $-0.06 for Q4 2024.
Did VolitionRX Limited beat estimates in Q4 2024?
Revenue missed the consensus estimate of $545.3K by $353.7K. EPS beat the consensus estimate of $-0.06 by $0.00.
Where can I find VolitionRX Limited's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001477932-25-002231) directly on SEC EDGAR. The filing index links above go to sec.gov.